Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations,
Study Type: Treatment
Phase: II
NCTID: NCT04320888
Principal Investigator:
Kevin Ginn
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Study Type: Treatment
Phase: III
NCTID: NCT02567435
Principal Investigator:
Keith August
Advancing Tobacco Use Treatment for African American Smokers
Study Type: Prevention
Phase: IV
NCTID: NCT02360631
Principal Investigator:
Lisa Cox
A Phase IB/II Study of Onvansertib PCM-075 in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation
Study Type: Treatment
Phase: I/II
NCTID: NCT03829410
Principal Investigator:
Anup Kasi
A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
Study Type: Prevention
Phase: III
NCTID: NCT02851407
Principal Investigator:
Rakesh Goyal
Blue Light Cystoscopy with Cysview Patient Registry
Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG
Study Type: Treatment
Phase: II
NCTID: NCT02684058
Principal Investigator:
Kevin Ginn
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Study Type: Treatment
Phase: II
NCTID: NCT03190915
Principal Investigator:
Kevin Ginn
Prospective Phase II Study of Cytochrome C Oxidase Activity as a Novel Biomarker In Subjects With Newly Diagnosed Primary Glioblastoma Multiforme
A Phase 3 Study of Active Surveillance for Low risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Study Type: Treatment
Phase: III
NCTID: NCT03067181
Principal Investigator:
Keith August